Aster DM Healthcare ASTERDM
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Research path: Interpret Aster DM Healthcare's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
AI analysis and Advanced tools for ASTERDM
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 8,111.96 | 6,606.38 | 17,991.31 |
| Cash Equivalents | 1,325.36 | 47.07 | 77.6 |
| Other Liabilities Total | 119.01 | 100.3 | 288.83 |
| Long Term Debt | 558.44 | 483.71 | 446.08 |
| Common Stock Total | 518.13 | 499.52 | 499.52 |
| Other Current Assets Total | 64.03 | 25.35 | 13,622 |
| Total Assets | 8,111.96 | 6,606.38 | 17,991.31 |
| Current Portof LT Debt/Capital Leases | 172.39 | 163.58 | 140.07 |
| Total Equity | 4,575.86 | 3,428.07 | 4,559.79 |
| Long Term Investments | 1,301.42 | 254.56 | 13.74 |
| Retained Earnings(Accumulated Deficit) | 4,057.73 | -17.72 | 1,071.13 |
| Total Common Shares Outstanding | 51.69 | 49.82 | 49.78 |
| Tangible Book Valueper Share Common Eq | 82.9 | 62.9 | 85.67 |
| Goodwill Net | 264.12 | 264.12 | 264.12 |
| Total Liabilities | 3,536.1 | 3,178.31 | 13,431.52 |
| Total Debt | 2,219.66 | 2,017.77 | 1,383.75 |
| Short Term Investments | 160.01 | 1,196.5 | 23.8 |
| Cashand Short Term Investments | 1,485.37 | 1,361.09 | 106.03 |
| Total Receivables Net | 307.23 | 384.12 | 283.12 |
| Deferred Income Tax | 132.82 | 146.12 | 247.63 |
| Accounts Receivable-Trade Net | 307.23 | 326.97 | 264.64 |
| Property/Plant/Equipment Total-Net | 4,370.87 | 3,918.57 | 3,049.95 |
| Minority Interest | 257.84 | 223.38 | 470.32 |
| Total Current Liabilities | 979.16 | 879.21 | 11,288.26 |
| Total Inventory | 91.16 | 114.07 | 137.57 |
| Accounts Payable | 481.51 | 426.2 | 458.7 |
| Other Currentliabilities Total | 325.26 | 258.14 | 10,580.1 |
| Total Long Term Debt | 2,047.27 | 1,829.3 | 1,136.48 |
| Intangibles Net | 26.27 | 30.32 | 31.38 |
| Other Long Term Assets Total | 126.44 | 78.24 | 118.53 |
| Note Receivable-Long Term | 75.05 | 159.1 | 348.29 |
| Total Current Assets | 1,947.79 | 1,901.47 | 14,165.3 |
| Capital Lease Obligations | 1,488.83 | 1,345.59 | 690.4 |
| Accumulated Depreciation Total | Not available | -1,048.76 | -880.89 |
| Accrued Expenses | Not available | 6.4 | 2.19 |
| Other Equity Total | Not available | 375.33 | 777.7 |
| Prepaid Expenses | Not available | 16.84 | 16.58 |
| Additional Paid-In Capital | Not available | 2,230.61 | 2,222.41 |
| Cash | Not available | 117.52 | 4.63 |
| Treasury Stock-Common | Not available | -8.23 | -10.97 |
| Property/Plant/Equipment Total-Gross | Not available | 4,676.59 | 3,760.74 |
| Notes Payable/Short Term Debt | Not available | 24.89 | 107.2 |
| Unrealized Gain(Loss) | Not available | 348.56 | Not available |
Valuation and ratios
Valuation
PEG Ratio2.2
Price to Sale Ratio9.51
Growth
Debt 5Yr CAGR %-14.31
Margins
Operating Margin 12m13.01
Operating Margin 5y Avg9.83
Net Profit Margin 12m9.2
Net Profit Margin 5y6.72
Yield
Dividend Yield %0.36
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk27.44
Analyst consensus
ConsensusStrong Buy
Consensus score1.73
Analyst opinions11
Strong Sell count0
Sell count0
Hold count0
Buy count8
Strong Buy count3
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Apollo Hospitals Enterprise | INR 8,812.9 | 1.27 L | 65.06 | — |
| Max Healthcare Institute | INR 1,075 | 1.05 L | 73.09 | — |
| Fortis Healthcare | INR 935 | 70,588.59 | 67.26 | — |
| Narayana Hrudayalaya | INR 1,881 | 38,187.34 | 48.55 | — |
| Global Health | INR 1,440.1 | 38,871.79 | 68.02 | — |
Ownership
- Promoter
- 53.72%
- FII
- 10.32%
- MF
- 15.93%
- Other
- 20.03%
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Nigeria, Aster DM Healthcare Explore Healthcare Training, Mobile Clinic Partnership Techeconomy
Boehringer Ingelheim and Aster DM Healthcare to improve medical education in UAE BioSpectrum Asia
BCP Asia increases stake in Aster DM to 29.71% via amalgamation scanx.trade
Movements. Aster DM Quality Care names Varun Khanna as MD and Group CEO Medical Buyer
Aster DM, Quality Care merger completed; combined entity begins ops The Times of India
Varun Khanna Appointed Managing Director & Group CEO at Aster DM Quality Care CXO Digitalpulse
Events
- board MeetingsQuarterly Results
- board MeetingsAudited Results
- annual General MeetingPOM
- dividendRs.3.0000 per share(30%)Interim Dividend
- board MeetingsInterim Dividend
- annual General MeetingCOM
- board MeetingsQuarterly Results & ESOP
- board MeetingsQuarterly Results & ESOP
- annual General MeetingAGM
- dividendRs.1.0000 per share(10%)Final Dividend
- board MeetingsQuarterly Results
- board MeetingsAudited Results & Final Dividend
- dividendRs.4.0000 per share(40%)Interim Dividend
- board MeetingsQuarterly Results & Interim Dividend
- annual General MeetingPOM
- board MeetingsQuarterly Results
- dividendRs.2.0000 per share(20%)Final Dividend
- annual General MeetingAGM
- board MeetingsQuarterly Results
- board MeetingsAudited Results & Final Dividend
Discussion and sentiment for Aster DM Healthcare
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Community discussion loads as you approach this section.
Business information
What the company does
Aster DM Healthcare Limited is an India-based healthcare service provider. The Company is operating in India with a presence across primary, secondary, tertiary, and quaternary healthcare through approximately 19 hospitals with 5,159 beds, 10 clinics, 203 pharmacies (Operated by Alfaone Retail Pharmacies Private Limited under brand license from Aster), and 262 labs and patient experience centers across five states in India. Its center of excellence includes Cardiac Sciences, Neurosciences, Gastro Sciences, Orthopaedics, Multi-Organ Transplant. Its pharmacy offers operating 203 pharmacies across southern India, delivering quality pharmaceutical, nutritional, infant care, lifestyle, and wellness products to communities and expanding healthcare access. Its labs deliver diagnostic services covering Biochemistry, Microbiology, Hematology, Clinical Pathology, Histopathology and Cytogenetics.
Company facts
- Industry
- Healthcare Facilities
- Sector
- Healthcare Facilities
- NSE Code
- ASTERDM
- BSE Code
- 540975
Stock FAQ
What is the symbol and ISIN of Aster DM Healthcare?
Aster DM Healthcare has the symbol ASTERDM and ISIN - INE914M01019.
What is the latest recorded price of Aster DM Healthcare?
The latest available recorded price of Aster DM Healthcare is INR 837.60 as of 2026-08-06T20:49:07.658Z. This is a source-stamped snapshot, not a live quote.
What are the year high and year low of Aster DM Healthcare?
Year high: INR 856.65. Year low: INR 519.80.
What is the market capitalization of Aster DM Healthcare?
Market capitalization: INR 44,157.18 crore.
What is the P/E ratio of Aster DM Healthcare?
P/E ratio: 88.86.
What is the dividend yield of Aster DM Healthcare?
Dividend yield: 0.36%.
How is the financial performance of Aster DM Healthcare based on revenue, net income, and EPS?
Revenue: INR 4,643.22 crore. Net income: INR 388.14 crore. EPS: INR 7.90.
What is the book value of Aster DM Healthcare?
Book value: INR 82.90.
What are the price-to-book and price-to-sales ratios of Aster DM Healthcare?
Price-to-book ratio: 10.10. Price-to-sales ratio: 9.51.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.

